Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2252-2258

  Kawai, Yasuhiro ^a   Miyashita, Naoyuki ^a   Kubo, Mika ^a   Akaike, Hiroto ^a   Kato, Atsushi ^a   Nishizawa, Yoko ^a   Saito, Aki ^a   Kondo, Eisuke ^a   Teranishi, Hideto ^a   Ogita, Satoko ^a   Tanaka, Takaaki ^a   Kawasaki, Kozo ^a   Nakano, Takashi ^a   Terada, Kihei ^a   Ouchi, Kazunobu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL RNA; CLARITHROMYCIN; ERYTHROMYCIN; MINOCYCLINE; RIBOSOME RNA; TOSUFLOXACIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CHILD; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE DURATION; DRUG EFFICACY; FEVER; GENDER; GENE MUTATION; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MINOCYCLINE; MUTATION; MYCOPLASMA PNEUMONIAE; NAPHTHYRIDINES; PNEUMONIA, MYCOPLASMA; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; TREATMENT OUTCOME;

EID: 84876275058     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00048-13     Document Type: Article

References (24)

1. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T. 2001. Characteristics of macrolideresistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol. Immunol. 45:617-620.
2. Matsuoka M, Narita M, Okazaki N, Ohya NH, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T. 2004. Characterization and molecular analysis of macrolideresistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48:4624-4630.
3. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, Nakayama E, Sunagawa K, Ubukata K, the Acute Respiratory Diseases Study Group. 2008. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 52:348-350.
4. Morozumi M, Takahashi T, Ubukata K. 2010. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16:78-86.
5. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, Okimoto N, Atypical Pathogen Study Group. 2012. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect. Dis. 12:126. doi:10.1186/1471-2334-12-126.
6. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M. 2009. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob. Agents Chemother. 53:2160-2162.
7. Wang Y, Qiu S, Yang G, Song L, Su W, Xu Y, Jia Y, Wang L, Hao R, Zhang Liu J, Fu X, He J, Zhang J, Li Z, Song H. 2012. An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school. Antimicrob. Agents Chemother. 56:3748-3752.
8. Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, Pereyre S. 2009. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother. 64:52-58.
9. Dumke R, von Baum H, Luck PC, Jacobs E. 2010. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin. Microbiol. Infect. 16:613-616.
10. Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, Quarto M, Cardinale F. 2011. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J. Antimicrob. Chemother. 66:734-737.
11. Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, Wiid Svarrer C. 2012. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 17:20073. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-20073.
12. Yamada M, Buller R, Bledose S, Storch GA. 2012. Rising rates of macrolide- resistant Mycoplasma pneumoniae in the central United States. Pediatr. Infect. Dis. J. 31:409-411.
13. Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. 2011. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg. Infect. Dis. 17:1079-1082.
14. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunagawa K, Iwata S. 2009. A comparative clinical study of macrolide-sensitive and macrolideresistant Mycoplasma pneumoniae infections in pediatric patients. J. Infect. Chemother. 15:380-383.
15. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T. 2006. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 50:709-712.
16. Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, Teranishi H, Inoue M, Wakabayashi T, Akaike H, Ogita S, Kawasaki K, Terada K, Kishi F, Ouchi K. 2012. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Respirology 17:354-362.
17. Committee for the Guidelines in Management of Respiratory Infectious Diseases in Children. 2011. Guidelines for the management of respiratory infectious diseases in children in Japan. In Ouchi K, Kurosaki T, Okada K (ed), Japanese Society of Pediatric Pulmonology/Japanese Society for Pediatric Infectious Diseases, Tokyo, Japan. (In Japanese.)
18. Ishida K, Kaku M, Irifune K, Mizukane R, Takemura H, Yoshida R, Tanaka H, Usui T, Tomono K, Suyama N. 1994. In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae. J. Antimicrob. Chemother. 34:875-883.
19. Niki Y, Hanaki H, Matsumoto T, Yagisawa M, Kohno S, Aoki N, Watanabe A, Sato J, Hattori R, Koashi N, Terada M, Kozuki T, Maruo A, Morita K, Ogasawara K, Takahashi Y, Matsuda K, Nakanishi K, Sunagawa K, Takeuchi K, Fujimura S, Takeda H, Ikeda H, Sato N, Niitsuma K, Saito M, Koshiba S, Kaneko M, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Aoki Y, Chonabayashi N, Sugiura H, Ichioka M, Goto H, Kurai D, Saraya T, Okazaki M, Yoshida K, Yoshida T, Tsukada H, Imai Y, Honma Y, Yamamoto T, Kawai A, Mikamo H, Takesue Y, Wada Y, Miyara T, Toda H, Mitsuno N, Fujikawa Y, Nakajima H, Kubo S, Ohta Y, Mikasa K, Kasahara K, Koizumi A, Sano R, Yagi S, Takaya M, Kurokawa Y, Kusano N, Mihara E, Nose M, Kuwabara M, Fujiue Y, Ishimaru T, Matsubara N, Kawasaki Y, Tokuyasu H, Masui K, Kido M, Ota T, Honda J, Kadota J, Hiramatsu K, Aoki Y, Nagasawa Z, Yanagihara K, Fujita J, Tateyama M, Totsuka K. 2011. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility. J. Infect. Chemother. 17:510-523.
20. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, Atypical Pathogen Study Group. 2011. Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur. J. Clin. Microbiol. Infect. Dis. 30:439-446.
21. Lucier TS, Heitzman K, Liu SK, Hu PC. 1995. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 39:2770-2773.
22. Waites KB, Crabb DM, Bing X, Duffy LA. 2003. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother. 47:161-165.
23. National Institute of Health Infectious Disease Surveillance Center. 2004. Mycoplasma pneumonia cases reported per sentinel weekly. National Institute of Health Infectious Disease Surveillance Center, Tokyo, Japan. http://idsc.nih.go.jp/idwr/kanja/weeklygraph/18myco.html.
24. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, Chiba N, Iwata S, Ubukata K. 2012. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin. Infect. Dis. 55: 1642-1649.